- Home
- PPBT vs SBFM Comparison
PPBT vs SBFM Comparison
Compare PPBT & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- SBFM
- Stock Information
- Founded
- PPBT 2010
- SBFM 2006
- Country
- PPBT Israel
- SBFM United States
- Employees
- PPBT N/A
- SBFM N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- PPBT Health Care
- SBFM Health Care
- Exchange
- PPBT Nasdaq
- SBFM Nasdaq
- Market Cap
- PPBT 6.2M
- SBFM 6.7M
- IPO Year
- PPBT N/A
- SBFM N/A
- Fundamental
- Price
- PPBT $2.08
- SBFM $1.47
- Analyst Decision
- PPBT Strong Buy
- SBFM Strong Buy
- Analyst Count
- PPBT 1
- SBFM 1
- Target Price
- PPBT $33.00
- SBFM $15.00
- AVG Volume (30 Days)
- PPBT 258.8K
- SBFM 195.5K
- Earning Date
- PPBT 08-15-2025
- SBFM 08-15-2025
- Dividend Yield
- PPBT N/A
- SBFM N/A
- EPS Growth
- PPBT N/A
- SBFM N/A
- EPS
- PPBT N/A
- SBFM N/A
- Revenue
- PPBT N/A
- SBFM $36,234,578.00
- Revenue This Year
- PPBT N/A
- SBFM $32.20
- Revenue Next Year
- PPBT N/A
- SBFM $32.74
- P/E Ratio
- PPBT N/A
- SBFM N/A
- Revenue Growth
- PPBT N/A
- SBFM 35.51
- 52 Week Low
- PPBT $2.00
- SBFM $1.17
- 52 Week High
- PPBT $13.95
- SBFM $6.00
- Technical
- Relative Strength Index (RSI)
- PPBT 32.49
- SBFM 44.40
- Support Level
- PPBT $2.35
- SBFM $1.50
- Resistance Level
- PPBT $2.90
- SBFM $1.61
- Average True Range (ATR)
- PPBT 0.17
- SBFM 0.08
- MACD
- PPBT -0.06
- SBFM -0.01
- Stochastic Oscillator
- PPBT 1.20
- SBFM 26.88
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.